Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy - a single-center open-label pilot study

We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subje...

Full description

Saved in:
Bibliographic Details
Published inNutritional neuroscience Vol. 26; no. 6; pp. 535 - 539
Main Authors Rasmussen, Emmaline, Patel, Vimal, Tideman, Samuel, Frech, Robert, Frigerio, Roberta, Narayanan, Jaishree
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 03.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement. Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects. Our data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial. MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative.
AbstractList We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement.OBJECTIVEWe set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement.Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects.METHODSAdult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects.Our data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial.RESULTSOur data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial.MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative.CONCLUSIONSMCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative.
We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement. Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects. Our data although limited by small sample size, shows that there is an estimated 42% reduction (p < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial. MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative.
We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy in a U.S. neurology clinical practice was associated with a reduction in number of seizures. We secondarily aimed to determine whether subjects experienced any side effects and whether there was a presence of urinary ketones while using MCT oil as a dietary supplement. Adult patients with intractable epilepsy were recruited at standard of care clinical visits with their epileptologist. Once enrolled, subjects were instructed to supplement their diet with MCT oil as tolerated twice daily for three months (including a 1-2 week titration period, followed by a 1-2 week tapering off window) while keeping a seizure diary to record total number of seizures, presence of urinary ketones, and any side effects. Our data although limited by small sample size, shows that there is an estimated 42% reduction (  < 0.0001) in the rate of seizures. The MCT oil supplementation was well tolerated by most subjects except for minor GI side effects like nausea and loose stools. Most subjects developed ketones in their urine at some point during the trial. MCT oil supplementation reduced seizure frequency in study participants. The reported side effects included mild nausea, stomachache, loose stools. A placebo-controlled study will be more informative.
Author Rasmussen, Emmaline
Tideman, Samuel
Frech, Robert
Patel, Vimal
Frigerio, Roberta
Narayanan, Jaishree
Author_xml – sequence: 1
  givenname: Emmaline
  surname: Rasmussen
  fullname: Rasmussen, Emmaline
  organization: NorthShore University HealthSystem
– sequence: 2
  givenname: Vimal
  surname: Patel
  fullname: Patel, Vimal
  organization: NorthShore University HealthSystem
– sequence: 3
  givenname: Samuel
  surname: Tideman
  fullname: Tideman, Samuel
  organization: NorthShore University HealthSystem
– sequence: 4
  givenname: Robert
  surname: Frech
  fullname: Frech, Robert
  organization: NorthShore University HealthSystem
– sequence: 5
  givenname: Roberta
  surname: Frigerio
  fullname: Frigerio, Roberta
  organization: NorthShore University HealthSystem
– sequence: 6
  givenname: Jaishree
  surname: Narayanan
  fullname: Narayanan, Jaishree
  email: kgulukota@yahoo.com
  organization: NorthShore University HealthSystem
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35470782$$D View this record in MEDLINE/PubMed
BookMark eNqFkTtvFDEUhS0URB7wE0AuaSb4MfbMiga0CiRSEM0WdJbXvo6MPPZge4QmDX8dr3ZDQQHNvVdX3znFOZfoLKYICL2m5JqSkbyjhI09Fd-uGWGsDSlGKp-hC9oPshs5EWftbkx3gM7RZSnfCWFUjPIFOueiH8gwsgv068Y5b7RZcXK4LPMcYIJYdcBftjucfMAp4gL-ccmAM9jFVN8-DdZ2CRXbvDx0GYovVceKYfYB5rLiDmtcfHwI0JnmBxmnGWIX9B4CblCquNTFri_Rc6dDgVenfYV2n25229vu_uvnu-3H-85wKWtnNRl13wN3jEpLrRbc2d6ZDTEA-15srBPWWk6lJntjNhQIMMf70Q6Gj4xfobdH2zmnHwuUqiZfDISgI6SlKCaFEJLKfmjomxO67Cewas5-0nlVT5k1QBwBk1MpGdwfhBJ16EY9daMO3ahTN033_i-d8VUf4qxZ-_Bf9Yej2keX8qR_physqnoNKbuso_FF8X9b_Aaoxqn5
CitedBy_id crossref_primary_10_1111_apha_14104
crossref_primary_10_1152_ajpcell_00241_2024
crossref_primary_10_1002_jbt_70213
crossref_primary_10_1007_s11101_024_09969_1
crossref_primary_10_1016_j_hnm_2024_200250
crossref_primary_10_3390_ijms25189869
crossref_primary_10_3390_nu14235003
Cites_doi 10.1002/epi4.12225
10.1111/j.1528-1167.2008.01821.x
10.1080/1028415X.2019.1627769
10.1016/j.eplepsyres.2012.06.007
10.1016/j.cell.2018.06.051
10.1097/01.nrl.0000160818.58821.d2
10.1111/j.1528-1167.2009.02397.x
10.1155/2013/809151
10.1016/j.eplepsyres.2011.04.009
10.1016/j.pediatrneurol.2006.01.005
10.1212/01.wnl.0000142991.14507.b5
10.1002/14651858
10.3390/nu12092645
10.1016/s0140-6736(98)05114-9
10.1111/j.1528-1167.2008.01870.x
10.1016/j.brainresrev.2008.09.002
10.1093/brain/awv325
10.1016/S1474-4422(08)70092-9
10.1007/s12519-017-0053-2
10.17265/2159-5313/2016.09.003
10.1212/wnl.21.11.1097
10.2147/JEP.S267029
10.1016/S1474-4422(17)30408-8
10.1016/j.neuropharm.2011.12.015
10.1111/j.1528-1167.2007.00915.x
ContentType Journal Article
Copyright 2022 Informa UK Limited, trading as Taylor & Francis Group 2022
Copyright_xml – notice: 2022 Informa UK Limited, trading as Taylor & Francis Group 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/1028415X.2022.2065816
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Diet & Clinical Nutrition
EISSN 1476-8305
EndPage 539
ExternalDocumentID 35470782
10_1080_1028415X_2022_2065816
2065816
Genre Research Article
Clinical Trial
Journal Article
GrantInformation_xml – fundername: NOW Foods
GroupedDBID ---
002
0BK
0R~
123
1~B
29N
2QV
36B
4.4
53G
A8Z
AALUX
AAMIU
AAPUL
AAQRR
ABBKH
ABDBF
ABEIZ
ABIVO
ABLCE
ABLIJ
ABUPF
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACKLR
ACUHS
ACVOX
ADCVX
ADXPE
AECIN
AENEX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
ARJSQ
BLEHA
BOHLJ
CCCUG
CS3
DXH
E01
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESTFP
ESX
F5P
H13
HCLVR
HZ~
KYCEM
LJTGL
M4Z
MV1
O9-
P2P
P76
P7B
RNANH
RVRKI
SV3
TBQAZ
TERGH
TFL
TFW
TUROJ
TUS
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
AMPGV
CITATION
5VS
ABGNL
ACWGZ
ADVEQ
AEIQB
AEXKJ
AFLJA
AGXXK
APIUT
AWYRJ
CAG
CGR
COF
COGVJ
CUY
CVF
ECM
EIF
EJD
M46
NPM
7X8
TASJS
ID FETCH-LOGICAL-c366t-da08a44e3f216d1da53fd4fc90ceeb459df5ddd316a0bcc91e0e2f348d7c3823
ISSN 1028-415X
1476-8305
IngestDate Tue Aug 05 10:57:26 EDT 2025
Wed Feb 19 02:23:40 EST 2025
Thu Apr 24 22:59:45 EDT 2025
Tue Jul 01 00:40:23 EDT 2025
Wed Dec 25 09:04:38 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords ketosis
Drug resistant epilepsy
dietary supplements
seizures
standard of care
intractable epilepsy
ketones
medium chain triglycerides
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c366t-da08a44e3f216d1da53fd4fc90ceeb459df5ddd316a0bcc91e0e2f348d7c3823
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 35470782
PQID 2655561647
PQPubID 23479
PageCount 5
ParticipantIDs informaworld_taylorfrancis_310_1080_1028415X_2022_2065816
pubmed_primary_35470782
crossref_primary_10_1080_1028415X_2022_2065816
crossref_citationtrail_10_1080_1028415X_2022_2065816
proquest_miscellaneous_2655561647
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-03
PublicationDateYYYYMMDD 2023-06-03
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-03
  day: 03
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Nutritional neuroscience
PublicationTitleAlternate Nutr Neurosci
PublicationYear 2023
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References Wilder RM. (CIT0017) 1921; 2
CIT0010
CIT0012
Geyelin HR. (CIT0006) 1921; 99
CIT0011
CIT0014
CIT0013
CIT0016
CIT0015
CIT0018
CIT0019
CIT0021
CIT0020
CIT0001
CIT0023
CIT0022
Guelpa G (CIT0005) 1911; 78
CIT0003
CIT0025
CIT0002
CIT0024
CIT0027
CIT0004
CIT0026
CIT0007
CIT0028
CIT0009
CIT0008
References_xml – ident: CIT0007
  doi: 10.1002/epi4.12225
– ident: CIT0018
  doi: 10.1111/j.1528-1167.2008.01821.x
– ident: CIT0024
  doi: 10.1080/1028415X.2019.1627769
– ident: CIT0009
  doi: 10.1016/j.eplepsyres.2012.06.007
– ident: CIT0027
  doi: 10.1016/j.cell.2018.06.051
– ident: CIT0015
  doi: 10.1097/01.nrl.0000160818.58821.d2
– ident: CIT0002
  doi: 10.1111/j.1528-1167.2009.02397.x
– ident: CIT0016
  doi: 10.1155/2013/809151
– ident: CIT0011
  doi: 10.1016/j.eplepsyres.2011.04.009
– ident: CIT0010
  doi: 10.1016/j.pediatrneurol.2006.01.005
– ident: CIT0003
  doi: 10.1212/01.wnl.0000142991.14507.b5
– ident: CIT0014
  doi: 10.1002/14651858
– ident: CIT0023
  doi: 10.3390/nu12092645
– volume: 2
  start-page: 307
  year: 1921
  ident: CIT0017
  publication-title: The Clinic Bulletin
– ident: CIT0004
  doi: 10.1016/s0140-6736(98)05114-9
– ident: CIT0012
  doi: 10.1111/j.1528-1167.2008.01870.x
– ident: CIT0026
  doi: 10.1016/j.brainresrev.2008.09.002
– volume: 99
  start-page: 1037
  year: 1921
  ident: CIT0006
  publication-title: Med Rec
– ident: CIT0022
  doi: 10.1093/brain/awv325
– ident: CIT0013
  doi: 10.1016/S1474-4422(08)70092-9
– ident: CIT0028
  doi: 10.1007/s12519-017-0053-2
– ident: CIT0001
  doi: 10.17265/2159-5313/2016.09.003
– ident: CIT0020
  doi: 10.1212/wnl.21.11.1097
– ident: CIT0008
  doi: 10.2147/JEP.S267029
– ident: CIT0019
  doi: 10.1016/S1474-4422(17)30408-8
– ident: CIT0021
  doi: 10.1016/j.neuropharm.2011.12.015
– volume: 78
  start-page: 8
  year: 1911
  ident: CIT0005
  publication-title: Revue de Thérapie Médico-Chirurgicale
– ident: CIT0025
  doi: 10.1111/j.1528-1167.2007.00915.x
SSID ssj0021586
Score 2.3784854
Snippet We set out to determine whether adding medium chain triglyceride (MCT) oil as a dietary supplement to standard diet in adult subjects with intractable epilepsy...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 535
SubjectTerms Adult
Diet, Ketogenic - adverse effects
dietary supplements
Drug resistant epilepsy
Drug Resistant Epilepsy - drug therapy
Humans
intractable epilepsy
Ketones
ketosis
medium chain triglycerides
Pilot Projects
seizures
Seizures - drug therapy
Seizures - prevention & control
standard of care
Triglycerides
Title Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy - a single-center open-label pilot study
URI https://www.tandfonline.com/doi/abs/10.1080/1028415X.2022.2065816
https://www.ncbi.nlm.nih.gov/pubmed/35470782
https://www.proquest.com/docview/2655561647
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELbK7oUL4p-ygIyEuEQpSeyk6XH_qhXSIoQK6i1yYhuK0qRqksPuCZ6BZ-JFeBJmEidNobAsl6hyY8fNfB2PxzPfEPIiwcObINa21F5gczce23GopS1hsY29hAGo0KF__iY4e89fz_35YPC9F7VUlfEoudyZV_I_UoU2kCtmyV5Dst2g0ACfQb5wBQnD9Z9kfIr8D1ivHSy-AstzKkPVf348s_JFiicBhVpc4iHBGjlaW_OwZt2w5Lr6aMN2G03IrLTUCjTEqriw2gAIZgkLXQmpsjGGU60trLVlA25UasHNedljp_3c5vEadn-YRY8rs4PPO1Esq6J1-yyXIu0d7L8Fw7d2SX9YLMUm9ANr2Bo_rVhWqvtiCtr60yY8vO_A8FgdaMV6Ord28Ln-vFmSmjY-DuyQOX5fUTep9QaQfa3rN4wnZgH3G3ak39aGJpgSn4YPG8FUMBEPLDB3Bxf3L2tkF7noGkrVdpgIh4nMMDfIvge7FVC3-4dHJ0fTbufv-nXJ0e6XtqlkofNq53y2jKQtCt0_b4Rqg2h2m9wyOxl62MDyDhmo7C4ZnixUSV9SQzeb0g4P98jXFq4017QPVwpwpQBXmmfUwJV2cMWba7jSbbjSFq70x5dvVNAtoNINUGkNVFoD9T6ZTU9nx2e2qQBiJywISlsKJxScK6Y9N5CuFD7Tkutk4oBtF3N_IrUvpWRuIJw4SSaucpSnGQ_lOMED7gdkL8sz9YjQ0GFcO45g8djlkkmRuPDaFVdqoqUInCHh7RuPEsOOj0Va0uivEh-SUddt1dDDXNVh0hdnVNZ-Od0U0YnYFX2ft7KPYBHAkz2RqbwqIi_wscxtwMdD8rABRTcd5vOaFfPxdad6QG5u_q5PyF65rtRTsMDL-JnB909ZPtc-
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+of+supplemental+MCT+oil+on+seizure+reduction+of+adult+drug-resistant+epilepsy+%E2%80%93+a+single-center+open-label+pilot+study&rft.jtitle=Nutritional+neuroscience&rft.au=Rasmussen%2C+Emmaline&rft.au=Patel%2C+Vimal&rft.au=Tideman%2C+Samuel&rft.au=Frech%2C+Robert&rft.date=2023-06-03&rft.issn=1028-415X&rft.eissn=1476-8305&rft.volume=26&rft.issue=6&rft.spage=535&rft.epage=539&rft_id=info:doi/10.1080%2F1028415X.2022.2065816&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_1028415X_2022_2065816
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1028-415X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1028-415X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1028-415X&client=summon